Implementing Long-Read Sequencing in Clinical Labs
As accessibility to long-read sequencing technologies like Oxford Nanopore and PacBio increases, clinical laboratories must assess their readiness for implementation.
As accessibility to long-read sequencing technologies like Oxford Nanopore and PacBio increases, clinical laboratories must assess their readiness for implementation.
Blood-based biomarker tests are revolutionizing Alzheimer's diagnostic testing and management of Alzheimer’s disease.
Breath tests are increasingly being explored and implemented in clinical diagnosis, offering a non-invasive means to detect a variety of conditions like blood cancer, lung disease, lower respiratory tract infections, and gastroparesis.
Siemens Healthineers has become the first to earn My Green Lab ACT Ecolabel Certification for both reagents and analyzers.
AI-enhanced EEG technology is emerging as a promising tool for early detection of Alzheimer's disease, potentially facilitating prevention efforts before symptoms appear.